Searched for
JAYARAM CHIGURUPATI
- Daiichi completes 20% acquisition in Zenotech
Japanese drug major Daiichi Sankyo on Wednesday said it has completed the open offer to purchase 20% stake in Hyderabad-based Zenotech Labo...
- Zenotech MD gets CLB nod to sell 10% in Daiichi open offer
The Company Law Board (CLB) has allowed Zenotech Laboratories’ founder and managing director Jayaram Chigurupati to sell a part of his 25% ...
- Daiichi's open offer for Zenotech to start from Aug 4
Zenotech Laboratories today said the open offer by Japanese drugmaker Daiichi Sankyo to acquire 20 per cent stake in it will start from Aug...
- 'Zenotech can't reappoint board members without permission'
The key body responsible for settling corporate disputes has told Zenotech Laboratories that it cannot reappoint two board members without ...
- CLB to hear Ranbaxy plea on Friday
The Company Law Board (CLB) will hear a complaint by Ranbaxy Laboratories, which is contesting the appointment of two independent directors...
- Ranbaxy loses to Zenotech in CLB
In a setback to India’s largest drugmaker Ranbaxy, the Company Law Board (CLB) has upheld the appointment of two directors on the board of ...
- Ranbaxy loses to Zenotech in Company Law Board
In a setback to India’s largest drug maker Ranbaxy, the Company Law Board (CLB) has upheld the appointment of two directors on the board of...
- CLB halts board meeting of Zenotech Laboratories
The Company Law Board (CLB) on Thursday stopped Hyderabad-based Zenotech Laboratories from holding its board meeting on Friday.
- Ranbaxy, Zenotech lock horns over board directors
Ranbaxy told the Company Law Board that Zenotech's founder MD Jayaram Chigurupati has no right to appoint the directors as he was attemptin...
- Ranbaxy-Zenotech lock horns over board directors
Ranbaxy Laboratories has objected to the appointment of two new directors to the board of Zenotech Laboratories, continuing a battle of att...
- FIPB rejects Zenotech plea against Daiichi
The country’s foreign investment regulator has rejected a plea by Zenotech Laboratories seeking the withdrawal of its earlier ruling that a...
- Zenotech told to hold board meeting on August 19
The founder of Zenotech Laboratories Jayaram Chigurupati managed to secure a minor victory from the Company Law Board (CLB), a day after mi...
- Zenotech shareholders take Ranbaxy to CLB over open offer pricing
The minority shareholders of Zenotech Laboratories have moved the Company Law Board (CLB) alleging mismanagement by Ranbaxy Laboratories, w...
- Zenotech moves CLB to remove Ranbaxy-appointed board members
Pharma firm Zenotech has approached the Company Law Board seeking removal of two of its board members, appointed by Ranbaxy, alleging "oper...
- Daiichi sticks to open offer price for Zenotech
Daiichi Sankyo, the new promoter of Ranbaxy, said it would not increase the open offer price of Rs 113.62 to buy a 20% stake in Hyderabad-b...
- Daiichi not to up open offer price to buy stake in Zenotech
Daiichi Sankyo will not increase the open offer price of Rs 113.62 to buy 20% stake in Hyderabad-based Zenotech Labs.
- Zenotech: Daiichi refuses to revise open offer price
Daiichi Sankyo, the new promoter of Ranbaxy, plans to buy 20% stake in Hyderabad-based Zenotech Labs has run into trouble after the Japanes...